Angele Maki

Angele Maki Email and Phone Number

Chief Business Officer @ Callio Therapeutics
California, United States
Angele Maki's Location
San Francisco Bay Area, United States, United States
Angele Maki's Contact Details
About Angele Maki

I am a biotech executive with scientific training and 20 years of business development experience in the biotech and pharma industries. I have a track record of sourcing and executing partnerships across multiple therapeutic areas and platforms.As the Chief Business Officer at Hummingbird Bioscience, I am steering the strategic growth, external collaborations, and investor relations of a company leading a bold new way of engineering precision biotherapeutics.

Angele Maki's Current Company Details
Callio Therapeutics

Callio Therapeutics

View
Chief Business Officer
California, United States
Angele Maki Work Experience Details
  • Callio Therapeutics
    Chief Business Officer
    Callio Therapeutics
    California, United States
  • Hummingbird Bioscience
    Chief Business Officer
    Hummingbird Bioscience Dec 2023 - Present
    Singapore, Sg
    Lead BD and IR for the company.
  • Pear Vc
    Biotech Industry Advisory Council Member
    Pear Vc Nov 2023 - Present
    Menlo Park, California, Us
    https://pear.vc/pear-healthcare-and-biotech-industry-advisory-council/
  • Paradox Immunotherapeutics
    Advisor
    Paradox Immunotherapeutics Apr 2021 - Present
    Toronto, Ontario, Ca
  • Recode Therapeutics
    Senior Vice President And Head Of Business Development
    Recode Therapeutics Aug 2021 - Nov 2023
    Menlo Park, California & Durham, North Carolina, Us
    *Led the business development and corporate development function.*Led the first platform deal with AskBio (affiliate of Bayer).*Led the IR and PR functions. *Helped raise $120M in a series B extension.
  • Eli Lilly And Company
    Vice President, Venture Science, Corporate Business Development
    Eli Lilly And Company 2019 - 2021
    Indianapolis, Indiana, Us
    *Role was to impact the Lilly pipeline with external platform technologies, early assets, and exciting companies through traditional business development activities and close partnership with Lilly's corporate venture group.*Helped establish Lilly Gateway Labs in SSF.*Example deals include Verge Genomics and Lycia Therapeutics.
  • Merck
    Executive Director, Business Development & Licensing
    Merck 2017 - 2019
    Rahway, New Jersey, Us
    *Led early-stage therapeutic search and evaluation efforts in oncology, immunology, & CRMO (cardio, renal, metabolic, & ophthalmology) on the West Coast of the US and Canada. *Executed on transactions to bring the best assets into Merck. *Led the Merck-Amunix deal from diligence through negotiations and execution.*Mentored startups in the Merck Invention Accelerator.
  • Genentech
    Associate Director, Business Development
    Genentech 2011 - 2017
    South San Francisco, California, Us
    *Led efforts to formulate strategy and in-license technologies for Genentech Research and Early Development (gRED). *Areas of focus included antibody engineering, small molecule drug discovery, human genetics, biomarkers/diagnostics, and genetic engineering tools. *Example deals include Ensemble, OMT, 23andMe, and HLI wherein I lead the diligence and negotiation through to execution.
  • Bristol Myers Squibb
    Director, Strategic Transactions Group
    Bristol Myers Squibb 2009 - 2011
    Lawrence Township, Nj, Us
    *Led in-licensing activities related to research technologies for Biologics Discovery California (legacy Medarex research group) and out-licensing of Medarex HumMAb platform. *Provide alliance management support for Medarex collaborations.
  • Medarex (Acquired By Bristol-Myers Squibb)
    Director, Business Development
    Medarex (Acquired By Bristol-Myers Squibb) 2004 - 2009
    *Executed 50/50 R&D collaborations with Celera and Compugen.*Outlicensed the Medarex antibody platform to small biotech & pharma.*Led efforts to source and in-license antibody and genetic engineering technologies.

Angele Maki Skills

Biopharmaceuticals Biotechnology Drug Discovery Drug Development Life Sciences Pharmaceutical Industry Lifesciences Immunology Monoclonal Antibodies Dna Licensing Molecular Biology Licensing Negotiations Biochemistry Strategy Technology Transfer Antibodies Business Development Oncology

Angele Maki Education Details

  • Women In Bio Boardroom Ready Program
    Women In Bio Boardroom Ready Program
  • Stanford University
    Stanford University
    Biological Chemistry
  • Scripps Research
    Scripps Research
    Molecular Biology
  • The University Of Winnipeg
    The University Of Winnipeg
    Chemistry

Frequently Asked Questions about Angele Maki

What company does Angele Maki work for?

Angele Maki works for Callio Therapeutics

What is Angele Maki's role at the current company?

Angele Maki's current role is Chief Business Officer.

What is Angele Maki's email address?

Angele Maki's email address is am****@****lly.com

What is Angele Maki's direct phone number?

Angele Maki's direct phone number is +165093*****

What schools did Angele Maki attend?

Angele Maki attended Women In Bio Boardroom Ready Program, Stanford University, Scripps Research, The University Of Winnipeg.

What skills is Angele Maki known for?

Angele Maki has skills like Biopharmaceuticals, Biotechnology, Drug Discovery, Drug Development, Life Sciences, Pharmaceutical Industry, Lifesciences, Immunology, Monoclonal Antibodies, Dna, Licensing, Molecular Biology.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.